Using 13 C 6 -glucose labelling, we see increased incorporation of labelled glucose into a range of metabolites (Fig
Contact your prescriber or clinical team if you notice: You're consistently eating fewer than 800 kcal per day for more than a week, despite trying to eat more Significant hair loss more than the usual shed, particularly from the crown or temples Persistent dizziness or light-headedness, especially on standing Extreme fatigue that is disproportionate to your activity level You cannot meet your protein minimum on most days, even with liquid nutrition and no-prep foods Nausea that prevents eating entirely for more than 2448 hours after injection These are not reasons to panic they are reasons to have a conversation
Constructed with NotebookLM using Kaneto H et al (2021) and Wexler (2025) as information resources
Tirzepatide (Mounjaro, Zepbound) targets GLP-1 and GIP, with a metabolic advantage that promotes fat breakdown while helping preserve muscle mass
That for some reason, that dosage, I don't know
The optimal incubation period (4 h) was used to assess the effect of UDE